“Our findings show how quickly patients and physicians accepted these new drugs because they profoundly reduce deaths from melanoma,” said c

A“one-two punch” that features a BRAF inhibitor plus a MEK inhibitor is an effective strategy to treat metastatic cutaneous melanoma,...